Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (181-190 of 451) with videos related to

Pageof 46
Sort By:
JTCVS Techniques|August 15, 2022
Successful use of a hepatitis C viremic donor in pediatric bilateral lobar lung transplantationMitsuaki Kawashima, Elias Seidl, Hartmut Grasemann, et al.
Scientific Reports|July 11, 2020
Optimized ex vivo stimulation identifies multi-functional HBV-specific T cells in a majority of chronic hepatitis B patientsConan G Chua, Aman Mehrotra, Tony Mazzulli, et al.
Hepatology (Baltimore, Md.)|December 25, 2009
Increased caffeine consumption is associated with reduced hepatic fibrosisApurva A Modi, Jordan J Feld, Yoon Park, et al.
European Radiology|July 28, 2018
The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitisKartik S Jhaveri, Hooman Hosseini-Nik, Nima Sadoughi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 21, 2020
Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over timeLauren Lapointe-Shaw, Hannah Chung, Beate Sander, et al.
Hepatology Communications|April 27, 2026
Multi-threshold analysis of the ELF Test versus histology for prognostication of disease progression and regression in MASHMatthew F W Gee, Rachel Fonstad, Edward B De Vol, et al.
Clinical and Translational Allergy|January 12, 2026
Association Between the Angioedema Control Test and Attack Frequency in Hereditary AngioedemaAaron Yarlas, Alexandra J Feld, Jakob B Bjorner, et al.
Journal of Viral Hepatitis|January 9, 2025
Resistance-Associated Substitution Testing Trends and Impact on HCV Treatment Outcomes in Canada: A CanHepC-CANUHC AnalysisHimain Perera, Haris Imsirovic, Gisela Macphail, et al.
The Journal of Infectious Diseases|October 31, 2024
Hepatitis B Virus RNA as a Biomarker for Safe Antiviral Discontinuation: A Prospective Study of Nucleos(t)ide Analogue WithdrawalNorah A Terrault, Richard Sterling, Anna S Lok, et al.
Infectious Diseases and Therapy|February 17, 2022
Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal HypertensionRobert S Brown, Michelle A Collins, Simone I Strasser, et al.
Pageof 46

Showing results (181-190 of 451) with videos related to

Sort By:
Pageof 46
JTCVS Techniques|August 15, 2022
Successful use of a hepatitis C viremic donor in pediatric bilateral lobar lung transplantationMitsuaki Kawashima, Elias Seidl, Hartmut Grasemann, et al.
Scientific Reports|July 11, 2020
Optimized ex vivo stimulation identifies multi-functional HBV-specific T cells in a majority of chronic hepatitis B patientsConan G Chua, Aman Mehrotra, Tony Mazzulli, et al.
Hepatology (Baltimore, Md.)|December 25, 2009
Increased caffeine consumption is associated with reduced hepatic fibrosisApurva A Modi, Jordan J Feld, Yoon Park, et al.
European Radiology|July 28, 2018
The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitisKartik S Jhaveri, Hooman Hosseini-Nik, Nima Sadoughi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 21, 2020
Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over timeLauren Lapointe-Shaw, Hannah Chung, Beate Sander, et al.
Hepatology Communications|April 27, 2026
Multi-threshold analysis of the ELF Test versus histology for prognostication of disease progression and regression in MASHMatthew F W Gee, Rachel Fonstad, Edward B De Vol, et al.
Clinical and Translational Allergy|January 12, 2026
Association Between the Angioedema Control Test and Attack Frequency in Hereditary AngioedemaAaron Yarlas, Alexandra J Feld, Jakob B Bjorner, et al.
Journal of Viral Hepatitis|January 9, 2025
Resistance-Associated Substitution Testing Trends and Impact on HCV Treatment Outcomes in Canada: A CanHepC-CANUHC AnalysisHimain Perera, Haris Imsirovic, Gisela Macphail, et al.
The Journal of Infectious Diseases|October 31, 2024
Hepatitis B Virus RNA as a Biomarker for Safe Antiviral Discontinuation: A Prospective Study of Nucleos(t)ide Analogue WithdrawalNorah A Terrault, Richard Sterling, Anna S Lok, et al.
Infectious Diseases and Therapy|February 17, 2022
Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal HypertensionRobert S Brown, Michelle A Collins, Simone I Strasser, et al.
Pageof 46